Biostatistics Symposium: Challenges and Opportunities in the Choice of Outcome Measures in Clinical Research

This year’s symposium will focus on the current challenges in choosing outcomes for clinical studies that evaluate treatments for disease and provide the necessary evidence to inform decision-making in clinical practice. Speakers from academia, the pharmaceutical industry, and the FDA will discuss the issues around creating a composite patient outcome that provides a more clinically relevant and informative evaluation and synthesis of treatment benefit, safety, and patient quality of life. The symposium is geared towards the interests of biostatisticians, epidemiologists, quantitative scientists, and clinical researchers.